Anxiety and depression in Australian chronic hepatitis C outpatients: Prevalence and predictors

Australasian Psychiatry

Volumn 20, Issue 6, 2012, Pages 496-500

  Stewart, Benjamin ^a   Mikocka Walus, Antonina ^a,b   Morgan, Joanne ^c   Colman, Anton ^c   Phelps, Megan ^c   Harley, Hugh ^c,d   Andrews, Jane ^c,d  

^a UNIVERSITY OF ADELAIDE   (Australia)

^b UNIVERSITY OF SOUTH AUSTRALIA   (Australia)

^c ROYAL ADELAIDE HOSPITAL   (Australia)

^d UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

anxiety; depression; hepatitis C; predictor; prevalence

Indexed keywords

ANTIVIRUS AGENT;

ANTIVIRAL THERAPY; ANXIETY DISORDER; ARTICLE; AUSTRALIA; COMORBIDITY; DEPRESSION; FEMALE; HEPATITIS C; HOSPITAL ANXIETY AND DEPRESSION SCALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MARRIAGE; OUTPATIENT; PREVALENCE; VIRUS TRANSMISSION;

ADULT; ANXIETY; AUSTRALIA; DEPRESSION; FEMALE; HEPATITIS C, CHRONIC; HUMANS; MALE; MIDDLE AGED; OUTPATIENTS; PREVALENCE; PSYCHIATRIC STATUS RATING SCALES; RISK FACTORS;

EID: 84874611736     PISSN: 10398562     EISSN: 14401665     Source Type: Journal    
DOI: 10.1177/1039856212460597     Document Type: Article

References (28)

1. Razali K, Thein HH, Bell J, et al. Modelling the hepatitis C virus epidemic in Australia. Drug Alcohol Depend. 2007 ; 91: 228-235
2. Liang J, Rehermann B, Seeff LB, et al. Pathogenesis, natural history, treatment, and prevention of hepatitis C. Ann Intern Med. 2000 ; 132: 296-305
3. Gidding HF, Topp L, Middleton M, et al. The epidemiology of hepatitis C in Australia: Notifications, treatment uptake and liver transplantations, 1997-2006. J Gastroenterol Hepatol. 2009 ; 24: 1648-1654
4. el-Serag HB, Kunik M, Richardson P, et al. Psychiatric disorders among veterans with hepatitis C infection. Gastroenterology. 2002 ; 123: 476-482
5. Dwight MM, Kowdley KV, Russo JE, et al. Depression, fatigue, and functional disability in patients with chronic hepatitis C. J Psychosom Res. 2000 ; 49: 311-317
6. Coughlan B, Sheehan J, Hickey A, et al. Psychological well-being and quality of life in women with an iatrogenic hepatitis C virus infection. Br J Health Psychol. 2002 ; 7: 105-116
7. Golden J, O'Dwyer AM, Conroy RM. Depression and anxiety in patients with hepatitis C: Prevalence, detection rates and risk factors. Gen Hosp Psychiatr. 2005 ; 27: 431-438
8. Loftis JM, Matthews AM, Hauser P. Psychiatric and substance use disorders in individuals with hepatitis C: Epidemiology and management. Drugs. 2006 ; 66: 155-174
9. Häuser W, Zimmer C, Schiedermaier P, et al. Biopsychosocial predictors of health-related quality of life in patients with chronic hepatitis C. Psychosom Med. 2004 ; 66: 954-958
10. Martín-Santos R, Díez-Quevedo C, Castellví P, et al. De novo depression and anxiety disorders and influence on adherence during peginterferon-alpha-2a and ribavirin treatment in patients with hepatitis C. Aliment Pharmacol Therapeut. 2008 ; 27: 257-265
11. Castera L, Constant A, Henry C, et al. Impact on adherence and sustained virological response of psychiatric side effects during peginterferon and ribavirin therapy for chronic hepatitis C. Aliment Pharmacol Therapeut. 2006 ; 24: 1223-1230
12. Leutscher PDC, Lagging M, Buhl MR, et al. Evaluation of depression as a risk factor for treatment failure in chronic hepatitis C. Hepatology. 2010 ; 52: 430-435
13. Mikocka-Walus AA, Turnbull DA, Andrews JM, et al. Psychological problems in gastroenterology outpatients: A South Australian experience. Psychological co-morbidity in IBD, IBS and hepatitis C. Clin Pract Epidemiol Ment Health. 2008 ; 4: 15
14. Bedossa P, Bioulac-Sage P, Callard P, et al. Intraobserver and interobserver variations in liver biopsy interpretation in patients with chronic hepatitis C. Hepatology. 1994 ; 20: 15-20
15. Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983 ; 67: 361-370
16. Bjelland I, Dahl AA, Haug TT, et al. The validity of the hospital anxiety and depression scale: An updated literature review. J Psychosom Res. 2002 ; 52: 69-77
17. Fábregas BC, Vitorino FD, Rocha DM, et al. Screening inventories to detect depression in chronic hepatitis C patients. Gen Hosp Psychiatr. 2012 ; 34: 40-45
18. Crawford JR, Henry JD, Crombie C, et al. Normative data for the HADS from a large non-clinical sample. Br J Clin Psychol. 2001 ; 40: 429-434
19. Erim Y, Tagay S, Beckmann M, et al. Depression and protective factors of mental health in people with hepatitis C: A questionnaire survey. Int J Nurs Stud. 2010 ; 47: 342-349
20. Evon DM, Ramcharran D, Belle SH, et al. Prospective analysis of depression during peginterferon and ribavirin therapy of chronic hepatitis C: Results of the virahep-C study. Am J Gastroenterol. 2009 ; 104: 2949-2958
21. Blasiole JA, Shinkunas L, LaBrecque DR, et al. Mental and physical symptoms associated with lower social support for patients with hepatitis C. World J Gastroenterol. 2006 ; 12: 4665-4672
22. Kraus MR, Schäfer A, Csef H, et al. Emotional state, coping styles, and somatic variables in patients with chronic hepatitis C. Psychosomatics. 2000 ; 41: 377-384
23. Mikocka-Walus AA, Turnbull D, Andrews JM, et al. Psychogastroenterology: A call for psychological input in Australian gastroenterology clinics. Intern Med J. 2009 ; 39: 127-130
24. Gunewardene R, Lampe L, Ilchef R. Prevalence of hepatitis C in two inpatient psychiatry populations. Australas Psychiatr. 2010 ; 18: 330-334
25. Seccull A, Richmond J, Thomas B, et al. Hepatitis C in people with mental illness: How big is the problem and how do we respond?. Australas Psychiatr. 2006 ; 14: 374-378
26. Third National Hepatitis C Strategy 2010-2013. Canberra: ; 2010 :
27. Kraus MR, Schäfer A, Schöttker K, et al. Therapy of interferon-induced depression in chronic hepatitis C with citalopram: A randomised, double-blind, placebo-controlled study. Gut. 2008 ; 57: 531-536
28. Neri S, Bertino G, Petralia A, et al. A multidisciplinary therapeutic approach for reducing the risk of psychiatric side effects in patients with chronic hepatitis C treated with pegylated interferon α and ribavirin.. 2010 ; 44: e210 - e217